Peptic Ulcer Hemorrhage
3
Pipeline Programs
4
Companies
2
Clinical Trials
1
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
1
0
1
1
Early DiscoveryClinical DevelopmentMarket
Drug Modality Breakdown
Small Molecule
2100%
On Market (1)
Approved therapies currently available
U
PANTOPRAZOLE SODIUMApproved
pantoprazole
Unknown Companyoral2016
Competitive Landscape
1 companies ranked by most advanced pipeline stage
PfizerNEW YORK, NY
2 programs1
1
PantoprazolePhase 3Small Molecule1 trial
PantoprazolePhase 2Small Molecule1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
PfizerPantoprazole
PfizerPantoprazole
Clinical Trials (2)
Total enrollment: 161 patients across 2 trials
Study Evaluating Pantoprazole in Peptic Ulcer Hemorrhage
Start: Apr 2001Est. completion: Jan 2003149 patients
Phase 3Completed
Study Evaluating Pantoprazole in Peptic Ulcer Hemorrhage
Start: Nov 2000Est. completion: Feb 200212 patients
Phase 2Completed
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 late-stage (Phase 3) programs — potential near-term approvals
4 companies competing in this space